Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3)

Diabet Med. 2024 Oct;41(10):e15387. doi: 10.1111/dme.15387. Epub 2024 Jun 14.

Henrik Maagensen^{1

2}, Sofie Hædersdal^{1

2}, Jesper Krogh^{1

3}, Torben Hansen⁴, Filip Krag Knop^{1

2

5}, Anne Cathrine Baun Thuesen^{1

4}, Tina Vilsbøll^{1

2

5}

¹ Copenhagen University Hospital-Steno Diabetes Center Copenhagen, Herlev, Denmark.
² Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, Hellerup, Denmark.
³ Department of Medicine, Clinic for Pituitary Disorders, Zealand University Hospital, Køge, Denmark.
⁴ Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

No abstract available

Publication types